NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001281

Registered date:31/07/2008

Strategic reduction of joint destruction in rheumatoid arthritis

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedRheumatoid arthritis
Date of first enrollment2008/07/01
Target sample size120
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)TNF-inhibitors plus MTX TNF-inhibitors are used for 54 weeks and exchange among them is approved MTX MTX is used for 54 weeks and addition of the other DMARD is approved

Outcome(s)

Primary OutcomeComparison of reduction of joint destruction between TNF-inhibitors and MTX alone.
Secondary Outcome(1) new bone erosion (2) DAS28 (3) EULAR-improvement criteria (4) HAQ

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients who met the following criteria are excluded. 1. patients with contra-indication to MTX 2. patients with contra-indication to TNF-inhibitors 3. patients who are not appropriate to the study by a doctor's judgement

Related Information

Contact

public contact
Name Kazuyoshi Saito
Address 1-1, Iseigaoka, Yahata-nishi-ku, Kitakyushu, 807-8555, Japan Japan
Telephone 093-603-1611
E-mail
Affiliation School of Medicine, University of Occupational and Environmental Health, Japan First Department of Internal Medicine
scientific contact
Name Yoshiya Tanaka
Address 1-1, Iseigaoka, Yahata-nishi-ku, Kitakyushu, 807-8555, Japan Japan
Telephone 093-603-1611
E-mail
Affiliation School of Medicine, University of Occupational and Environmental Health, Japan First Department of Internal Medicine